US Stock MarketDetailed Quotes

ITCI Intra-Cellular Therapies

Watchlist
  • 83.450
  • -0.690-0.82%
Close Dec 20 16:00 ET
  • 83.450
  • 0.0000.00%
Post 20:01 ET
8.85BMarket Cap-95.92P/E (TTM)

Intra-Cellular Therapies Key Stats

Intra-Cellular Therapies Q3 2024 Earnings Date

Currency:USDOct 30, 2024

Estimate
(YoY)
Actual
(YoY)
Vs Estimate
(% Chg)
Revenue
172.35M
175.38M
+3.02M
Beat Est.
+36.60%
+39.00%
+1.75%
EPS
-0.21
-0.25
-0.04
Miss Est.
+16.37%
--
-19.62%
Strong Buy

Dec 5, 2024

Intra-Cellular Therapies Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 7 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 197.759M--
--2024/Q4-- / 194.051M--
Oct 30, 20242024/Q3175.375M / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--
May 7, 20242024/Q1144.866M / 141.444M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 197.759M--
--2024/Q4-- / 194.051M--
Oct 30, 20242024/Q3175.375M / 172.353M--
Aug 7, 20242024/Q2161.388M / 157.884M--
May 7, 20242024/Q1144.866M / 141.444M--

Unlock Free Earnings Estimates

Intra-Cellular Therapies Earnings Reports

Read more

Analysis

Analyst Rating

Updated: Dec 5, 2024

Strong Buy

  • Buy

    85.71%
  • Hold

    14.29%
  • Sell

    0.00%

Price Target

No Data

Heat List
US
Overall
Symbol
Price
% Chg

No Data